Barrier Therapeutics News
Most Popular Barrier Therapeutics Story
Stiefel forges deal to acquire Barrier Therapeutics
Stiefel Laboratories is buying Barrier Therapeutics - a developer of dermatology products - in a deal valued at $148 million. Stiefel is paying $4.15 a share for the company. In exchange, Stiefel Read more...
Latest Headlines
- June 23, 2008
- March 19, 2008
- October 19, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
